Regulation & Compliance

The high-tech wheel maker's stock plummets 65% as it fails to meet listing rules, signaling deep financial and operational distress for the company.

Republic Technologies taps Canadian Solar’s CFO, signaling a strategic move to blend traditional financial discipline with Web3 infrastructure development.

With a massive Bitcoin injection, TIRX aims for stablecoin dominance in ASEAN, but faces a maze of regulatory hurdles and unproven technical claims.

A European company with Big Pharma roots brings its natural allergy aid, SnizIQ, to California, tapping into a growing demand for alternatives.

EMD Serono and the Trump Administration launch a new program offering massive discounts on IVF drugs, bringing hope to millions of aspiring parents.

Marex's acquisition of Webb Traders signals a major push into automated equity derivatives, aiming to internalize hedging and challenge market norms.

Aucta Pharma launches two rare disease drugs, PYQUVI and ZELVYSIA, betting on a 'branded-generic' model to navigate highly competitive markets.

After a bitter legal battle across Europe, Maxeon and Aiko sign a landmark patent agreement, reshaping the global market for high-efficiency solar tech.

The emirate launches a pioneering customs duty waiver for high-value art, aiming to become a top global hub with a focus on transparency and security.

As HUTCHMED prepares to unveil its 2025 financials, investors weigh a complex picture of global drug success, domestic pressures, and pipeline promise.

Akeso's innovative dual-action antibody secures its fifth breakthrough nod, offering a lifeline for patients with advanced biliary tract cancer.

Stunning real-world data shows Iovance's Amtagvi is more effective in earlier melanoma treatment, potentially changing clinical practice and offering new hope.

Stablecoin giant Tether's $150M investment in Gold.com signals a new era, merging physical gold with blockchain to redefine asset ownership.

As Amwell prepares its 2025 results, investors watch to see if its strategic pivot to profitability can redefine the future of digital healthcare.

The biotech celebrates its first FDA drug approval, a massive financial boost, and promising new therapies targeting obesity and Alzheimer's disease.

As sports betting ads flood the airwaves for the Super Bowl, experts warn of a hidden crisis of illegal underage gambling and equip parents to fight back.

The deli giant reopens its Jarratt, VA facility with new tech and top experts after a fatal Listeria crisis. It's a high-stakes bet on rebuilding trust.

After clearing the EU's rigorous MDR hurdle, P&F's novel heart valve system secures its European future and sets its sights on the lucrative US market.

As NATO's transformation chief prepares to speak in D.C., a new U.S. strategy calls for a radical increase in allied defense spending and responsibility.

Zip US launches 'Pay in 2,' moving the BNPL model from large purchases to daily essentials like groceries, aiming to help consumers manage cash flow.